HPV infection: immunological aspects and their utility in future therapy
about
Human papillomaviruses-related cancers. Presence and prevention strategies in the Middle east and north African regionsClearance of persistent HPV infection and cervical lesion by therapeutic DNA vaccine in CIN3 patients.Placenta growth factor promotes migration through regulating epithelial-mesenchymal transition-related protein expression in cervical cancer.Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancer.Candidate Soluble Immune Mediators in Young Women with High-Risk Human Papillomavirus Infection: High Expression of Chemokines Promoting Angiogenesis and Cell Proliferation.Expression quantitative trait loci in long non-coding RNA ZNRD1-AS1 influence cervical cancer developmentHuman Papillomavirus (HPV) Infection: Molecular Epidemiology, Genotyping, Seroprevalence and Associated Risk Factors among Arab Women in Qatar.Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4+ T Cells.LSD1 binds to HPV16 E7 and promotes the epithelial-mesenchymal transition in cervical cancer by demethylating histones at the Vimentin promoter.Analysis of rs8067378 Polymorphism in the Risk of Uterine Cervical Cancer from a Polish Population and its Impact on Gasdermin B Expression.The cost-effectiveness of HPV vaccination in addition to screening: a Dutch perspective.Toll-like receptor 4 promotes proliferation and apoptosis resistance in human papillomavirus-related cervical cancer cells through the Toll-like receptor 4/nuclear factor-κB pathway.Immune Modulation and Treatment of Human Papilloma Virus-Related Warts with Energetics of Living Systems Acupuncture.Comment on 'The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study'Clinical Significance of CD163+ and CD68+ Tumor-associated Macrophages in High-risk HPV-related Cervical Cancer.Effect of Dialyzable Leukocyte Extract on chronic cervicitis in patients with HPV infection.TGF-β1-induced CK17 enhances cancer stem cell-like properties rather than EMT in promoting cervical cancer metastasis via the ERK1/2-MZF1 signaling pathway.Evaluation of immune responses induced by a novel human papillomavirus type 16 E7 peptide-based vaccine with Candida skin test reagent as an adjuvant in C57BL/6 mice.Murine HPV16 E7-expressing transgenic skin effectively emulates the cellular and molecular features of human high-grade squamous intraepithelial lesions.17β-hydroxysteroid dehydrogenase type Gene 1937 A > G Polymorphism as a Risk Factor for Cervical Cancer Progression in the Polish Population.Activities of stromal and immune cells in HPV-related cancers.
P2860
Q34291224-0C4DB7F1-3ADC-408B-81E3-DB277B241DF3Q34453827-42D2D434-927B-4E94-9B6F-38A3BA03D310Q35038699-E91B5392-C211-46CA-936C-847E92C9C520Q35871517-047707DC-3D85-4E5D-94C8-CB923FA6ED0DQ35962518-A7063094-C956-4CF8-8E4B-F1D8DDB6EC14Q35993181-05E9252E-172D-47DD-AD76-4B58C4E4CE68Q36238267-5774F3EF-854E-4E46-B2B3-69F513361867Q37667998-8F96DD53-818A-4F0B-AE92-0DEB098C3D6AQ37706908-149A7F40-3A76-40DD-8790-486D31FED9FAQ37707356-5FC81F92-6C76-4C5E-903B-6560B72184F6Q38284334-2C982ABD-3CD0-4231-9F0C-A103EF45484BQ38707367-8F2F2B0D-FFD5-40C9-9649-B9BEDEEAB673Q40111267-40B5C020-A4DE-4E82-86D5-2723A376D3A9Q41398206-A02625DE-FFA8-4CAC-9F88-0FE40F518F45Q47157554-D33EE4CF-D8E1-4CC2-9539-6ABC8ADA80D7Q47549506-04B90163-1324-4F20-9459-AC20F3375347Q48132057-55453758-07F5-433C-8FB2-417DB2583CD9Q50134597-A4CB28DA-739F-47A4-8F4A-DC7E173FBD7BQ54937688-3711AD0C-30B9-486D-9A77-CC6A0949DC02Q55059838-E0226918-7DB5-49A0-9565-60DD28C9A08DQ55507801-833B3133-6DE3-490E-82B9-DCDD26FC02AD
P2860
HPV infection: immunological aspects and their utility in future therapy
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
HPV infection: immunological aspects and their utility in future therapy
@en
HPV infection: immunological aspects and their utility in future therapy.
@nl
type
label
HPV infection: immunological aspects and their utility in future therapy
@en
HPV infection: immunological aspects and their utility in future therapy.
@nl
prefLabel
HPV infection: immunological aspects and their utility in future therapy
@en
HPV infection: immunological aspects and their utility in future therapy.
@nl
P2093
P2860
P921
P356
P1476
HPV infection: immunological aspects and their utility in future therapy
@en
P2093
Aikaterini Giannouli
Anastasia Vatopoulou
Efthimios Deligeoroglou
George Creatsas
Konstantinos Dimopoulos
Nikolaos Athanasopoulos
Vasileios Karountzos
P2860
P304
P356
10.1155/2013/540850
P577
2013-08-20T00:00:00Z